Medical care of patients with Wilson disease in Germany: a multidisciplinary survey among university centers

[1]  M. Washington,et al.  A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases. , 2022, Hepatology.

[2]  Y. Izumi,et al.  Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study , 2021, BMJ Paediatrics Open.

[3]  T. Sandahl,et al.  The Prevalence of Wilson’s Disease: An Update , 2020, Hepatology.

[4]  Ren-min Yang,et al.  The study of Wilson disease in pregnancy management , 2019, BMC Pregnancy and Childbirth.

[5]  A. Poujois,et al.  New tools for Wilson's disease diagnosis: exchangeable copper fraction. , 2019, Annals of translational medicine.

[6]  J. Dooley,et al.  ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease , 2020, Human Genetics.

[7]  K. Zieniewicz,et al.  2018 Annual Report of the European Liver Transplant Registry (ELTR) – 50‐year evolution of liver transplantation , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  C. Lohse,et al.  Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment , 2018, Journal of Inherited Metabolic Disease.

[9]  L. D’Antiga,et al.  Wilson's Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. , 2017, Journal of pediatric gastroenterology and nutrition.

[10]  A. Członkowska,et al.  Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease. , 2015, Functional neurology.

[11]  J. Mayerle,et al.  Erste Daten zur Versorgungssituation von Patienten mit nicht alkoholischer Fettlebererkrankung (NAFLD) in Deutschland – Eine Umfrage an universitären hepatologischen Zentren , 2014, Zeitschrift für Gastroenterologie.

[12]  Raffaele Iorio,et al.  Zinc monotherapy is effective in Wilson’s disease patients with mild liver disease diagnosed in childhood: a retrospective study , 2014, Orphanet Journal of Rare Diseases.

[13]  Yan Lin,et al.  Comprehensive analysis on clinical features of Wilson’s disease: an experience over 28 years with 133 cases , 2014, Neurological research.

[14]  J. Walshe.  The acute haemolytic syndrome in Wilson's disease--a review of 22 patients. , 2013, QJM : monthly journal of the Association of Physicians.

[15]  W. Stremmel,et al.  EASL Clinical Practice Guidelines: Wilson's disease. , 2012, Journal of hepatology.

[16]  F. Woimant,et al.  Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[17]  M. Schaefer,et al.  Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. , 2011, Gastroenterology.

[18]  Matthew T. Lorincz,et al.  Neurologic Wilson's disease , 2010, Annals of the New York Academy of Sciences.

[19]  F. Woimant,et al.  Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects , 2009, Analytical and bioanalytical chemistry.

[20]  M. Schilsky,et al.  Diagnosis and treatment of Wilson disease: An update , 2008, Hepatology.

[21]  G. Arunodaya,et al.  Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades , 2007, Medicine.

[22]  M. Schaefer,et al.  Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study , 2006, Gut.

[23]  Ali Akbar Asadi Pooya,et al.  Wilson disease in southern Iran. , 2005, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[24]  D. Cox,et al.  Diagnosis and phenotypic classification of Wilson disease 1 , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[25]  A. Herneth,et al.  Wilson's disease in patients presenting with liver disease: a diagnostic challenge. , 1997, Gastroenterology.

[26]  G. Brewer,et al.  Wilson Disease , 1992, Medicine.

[27]  H. Hefter,et al.  Wilson disease: clinical presentation, treatment, and survival. , 1991, Annals of internal medicine.

[28]  H. Ikematsu,et al.  Fulminant hepatic failure during perinatal period in a pregnant woman with Wilson’s disease , 1991, Gastroenterologia Japonica.

[29]  M. Aladjem,et al.  Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease , 1989, European Journal of Pediatrics.

[30]  E. Picard,et al.  Wilson's disease associated with pancreatitis. , 1988, Journal of pediatric gastroenterology and nutrition.

[31]  A. Aisen,et al.  Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. , 1987, Archives of neurology.

[32]  T. Hoogenraad,et al.  Management of Wilson's disease with zinc sulphate Experience in a series of 27 patients , 1987, Journal of the Neurological Sciences.

[33]  A. Dixon,et al.  DANGERS OF NON-COMPLIANCE IN WILSON'S DISEASE , 1986, The Lancet.

[34]  D. Wiebers,et al.  Renal stones in Wilson's disease. , 1979, The American journal of medicine.

[35]  T. Hoogenraad,et al.  ORAL ZINC IN WILSON'S DISEASE , 1979, The Lancet.

[36]  S. Sherlock,et al.  Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens. , 1977, British medical journal.

[37]  J. Benhamou,et al.  Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. , 1977, Annals of internal medicine.

[38]  A. Członkowska.  A study of haemolysis in Wilson's disease. , 1972, Journal of the neurological sciences.

[39]  B. Fleischer.  Über eine der „Pseudosklerose“ nahestehende bisher unbekannte Krankheit (gekennzeichnet durch Tremor, psychische Störungen, bräunliche Pigmentierung bestimmter Gewebe, insbesondere auch der Hornhautperipherie, Lebercirrhose) , 1912, Deutsche Zeitschrift für Nervenheilkunde.

[40]  S. A. Wilson.  PROGRESSIVE LENTICULAR DEGENERATION : A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER. , 1912 .

[41]  S. A. Wilson,et al.  PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER , 1912 .

[42]  F. Tacke,et al.  [First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology]. , 2015, Zeitschrift fur Gastroenterologie.

[43]  Red..  Leitlinien für Diagnostik und Therapie in der Neurologie , 2012, NeuroTransmitter.

[44]  C. Klötzsch,et al.  Leitlinien für Diagnostik und Therapie in der Neurologie , 2012 .

[45]  Meier,et al.  Leitlinien für Diagnostik und Therapie in der Neurologie: Herausgegeben von der Kommission „Leitlinien“ der Deutschen Gesellschaft für Neurologie (DGN) , 2008 .

[46]  Peter Bross,et al.  The Metabolic and Molecular Basis of Inherited Disease: Protein Folding and Misfolding: the Role of Cellular Protein Quality Control Systems in Inherited Disorders , 2005 .

[47]  S. Factor,et al.  The cardiomyopathy of Wilson's disease , 2004, Virchows Archiv A.

[48]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[49]  H. Cheong,et al.  Recurrent Hypokalemic Muscle Weakness as an Initial Manifestation of Wilson’s Disease , 1996 .